Related Experiment Video
Updated: Apr 23, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
Published on: January 20, 2023
The J-curve in arterial hypertension: fact or fallacy?
Evangelia P Tsika1, Leonidas E Poulimenos, Konstantinos Dean Boudoulas
1Cardiology Department, Asklepeion Hospital, Athens, Greece.
Insights
Many patients with high blood pressure are undertreated, increasing cardiovascular risks. However, overly aggressive blood pressure reduction can also be harmful, especially in those with coronary artery disease or left ventricular hypertrophy.
Area of Science:
- Cardiology
- Hypertension Management
Background:
- A significant number of patients with arterial hypertension remain undertreated, contributing to increased cardiovascular event rates.
- Conversely, overly aggressive blood pressure reduction can paradoxically elevate cardiovascular events, a phenomenon known as the J-curve.
Purpose of the Study:
- To review the J-curve phenomenon in hypertension management.
- To identify patient populations at risk for adverse outcomes with aggressive blood pressure lowering.
- To discuss updated guideline recommendations for safer blood pressure targets.
Main Methods:
- Literature review of studies on blood pressure management and cardiovascular outcomes.
- Analysis of the J-curve phenomenon in specific patient subgroups.
- Examination of current European hypertension guidelines.
Main Results:
- The J-curve phenomenon, where excessively low blood pressure increases cardiovascular events, is observed in patients with coronary artery disease and left ventricular hypertrophy when diastolic blood pressure falls below 70-80 mm Hg or systolic below 130 mm Hg.
- This phenomenon is not typically seen in patients with stroke or renal disease.
- Recent guidelines suggest higher blood pressure targets for specific patient groups, including the elderly and those with certain cardiovascular conditions.
Conclusions:
- A conservative blood pressure management strategy is crucial for patients with coronary artery disease, left ventricular hypertrophy, the elderly, and isolated systolic hypertension.
- Adherence to updated European Society of Hypertension/European Society of Cardiology guidelines is recommended for optimizing patient outcomes.
- Individualized blood pressure targets are essential to balance the risks of undertreatment and overtreatment.
Abstract:
It is known that a large proportion of patients with arterial hypertension are undertreated. This may result in an increase of the incidence of cardiovascular events. On the other hand, aggressive reduction of blood pressure may increase cardiovascular events (J-curve phenomenon) in certain populations. This phenomenon may be seen in patients with coronary artery disease and left ventricular hypertrophy when the diastolic blood pressure decreases below 70-80 mm Hg, and the systolic blood pressure decreases below 130 mm Hg. This phenomenon is not seen in patients with stroke or renal disease. Thus, a safer and more conservative strategy should be applied in patients with coronary artery disease, left ventricular hypertrophy, elderly, and in patients with isolated systolic hypertension. This is depicted in the recently published European Society of Hypertension/European Society of Cardiology guidelines in which higher targets of blood pressure are suggested in certain cardiovascular diseases and in the elderly.
More Related Videos
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Portal Hypertension

